777 Initial clinical characterization of novel proximal biomarkers for NX-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced malignanciesSarah Whelan, Janine Powers, Ruth Plummer et al.|Regular and Young Investigator Award Abstracts|2022Cited by 2